1. Home
  2. TVRD vs GIGM Comparison

TVRD vs GIGM Comparison

Compare TVRD & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tvardi Therapeutics Inc.

TVRD

Tvardi Therapeutics Inc.

SELL

Current Price

$1.09

Market Cap

15.7M

Sector

Health Care

ML Signal

SELL

GIGM

GigaMedia Limited

SELL

Current Price

$1.37

Market Cap

15.3M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
TVRD
GIGM
Founded
2017
1998
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
15.3M
IPO Year
2013
2002

Fundamental Metrics

Financial Performance
Metric
TVRD
GIGM
Price
$1.09
$1.37
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $8.88
N/A
AVG Volume (30 Days)
★ 207.0K
11.4K
Earning Date
11-13-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.01
N/A
EPS
N/A
★ N/A
Revenue
★ $911,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 959.30
N/A
52 Week Low
$0.77
$1.11
52 Week High
$5.69
$1.63

Technical Indicators

Market Signals
Indicator
TVRD
GIGM
Relative Strength Index (RSI) 50.87 53.17
Support Level $0.85 $1.30
Resistance Level $2.02 $1.48
Average True Range (ATR) 0.17 0.04
MACD 0.05 0.01
Stochastic Oscillator 41.46 65.22

Price Performance

Historical Comparison
TVRD
GIGM

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.

Share on Social Networks: